Lifeboat Foundation

Melanie Matheu is the CEO of Prellis Biologics. As a scientist, entrepreneur and somebody with a huge vision about the future of organ replacement this podcast literally asks what if we could print life from light. Laser-printing organs and vascular systems to give everybody another chance has incredible value. It changes the dynamics of how to handle endemic diseases like diabetes and many other organ issues, liver, kidney and maybe eventually very complex systems like the nervous systems inside our bodies. It’s a two-part podcast because the range of ideas and possibilities this brings up are almost infinite.

What if you could get life from light? Our guest today is doing exactly that. From laser printing of vascular elements to eventual full laser printing of organs from kidneys to livers and maybe eventually nervous systems, the ideas today are well within the grasp of reality in ten years’ time. Just imagine how this will change our medical systems, what doctors focus on and how we solve major global health crisis like diabetes. Imagine how it could give huge numbers of us a second, third or even fourth career as it expands life into the 80s, 90s and beyond.

Everybody who listens to these two podcasts will be affected directly or indirectly by the ideas Melanie is bringing to life. There is a very different to the future of organs, one that is far closer than we might have thought possible. That also means the questions and ideas about how we manage our bodies are going to change, very quickly.

Today, Kansas City became the first major American city to have fare-free public transit.

City council voted unanimously to make city bus routes fare-free, reports KSHB, directing the city manager to develop and enact a plan. The city’s light rail was already free.

Free bus service, which is expected to cost about $8 million, has been pitched as a major help to low-income residents who rely on transit to commute to work.

Researchers discovered a new malicious activity that involved by Russian APT hackers to attack Government and Military officials in Ukrainian entities.

The attacker’s targets are not limited but they also infect various individuals who is part of the government and Law enforcement, Journalists, Diplomats, NGO and the Ministry of Foreign Affairs.

Researchers believe that the campaign attributed to Gamaredon activity in which attackers using Dynamic Domain Name Server as C2 server, VBA macro, and VBA script as a part of this attack.

Last week, a woman named Victoria Gray became the first person in the U.S. to have her cells edited with CRISPR. The 41-year-old patient was suffering from sickle cell anemia.

RELATED: FIRST HUMAN TRIAL USING CRISPR GENE-EDITING IN US BEGINS

The condition, caused by a genetic mutation that messes with the shape of red blood cells, causes havoc on patients, and to make things even worse, the options for treatment are very limited and ineffective. The only current treatment for sickle cell anemia patients is a donor transplant that works for just 10% of patients, but all that is about to change.

But for some reason it named every character “Dan.”

Rejuvenation Biotechnology: on track to be the biggest industry ever.

Dr Aubrey de Grey, CSO at the SENS Research Foundation speaking at Master Investor’s Investing in the Age of Longevity 2019 event. Aubrey discusses Rejuvenation biotechnology and how it’s on track to become the biggest industry ever.

Continue reading “Dr Aubrey de Grey | Investing in the Age of Longevity 2019” »

One of the most vexing questions many of us face once we hit our 60s is: Where should we live as we get older? I’m not talking about those “Best Places to Live” rankings. I mean what kind of home, and type of community, would be most suitable. That’s why I was eager to hear what several gerontologists had to say in their session at last week’s Gerontological Society of America conference about how they decided where they’d live in later life.

What kind of home and community is most suitable? The answer isn’t always rational.

Gene therapies to reverse immunosenescence and atherosclerosis.

CEO of Repair Biotechnologies speaking at Master Investor’s Investing in the Age of Longevity 2019 event. Reason discusses gene therapies to reverse immunosenescence and atherosclerosis.

Continue reading “Reason | Investing in the Age of Longevity 2019” »

Your space questions, answered.